• news.cision.com/
  • Artimplant/
  • Anders Cedronius, Chairman of the Board, has announced that he will not be available for re-election to the Board at the upcoming AGM on May 7, 2013.
English

Anders Cedronius, Chairman of the Board, has announced that he will not be available for re-election to the Board at the upcoming AGM on May 7, 2013.

Report this content

Västra Frölunda, March 26, 2013

Lars Peterson
Board Member and Chairman of the Nomination Committee
  

For further information, please contact:
Lars Peterson
E-mail: peterson.lars@telia.com
Telephone: +46 702 91 41 86

Further information is available at www.artimplant.com where you can also subscribe to future press releases; www.artimplant.com/investors-media/subscribe-to-press-releases.html

Artimplant
Artimplant is a biomaterials company focused on solutions to problems in orthopedics. We restore health through the development, production and marketing of degradable implants that regenerate body functions and improve quality of life. Our products, made from Artelon®, meet unmet clinical needs and are marketed in a growing number of therapy areas. Artimplant produces implants for treatment of osteoarthritis in hands and feet as well as shoulder and other soft tissue injuries.
Artimplant is a public company, listed on NASDAQ OMX Stockholm in the Small Cap segment and in the healthcare sector.

Forward-looking statements
This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting on the Company's business, including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks detailed from time to time in the Company's filings.

This is information that Artimplant will make public pursuant to the Swedish Financial Instruments Act and the Swedish Securities Exchange and Clearing Operations Act and/or stock market agreements. Information was made available for publication on March 26, 2013 at 11 am (Swedish time).

Documents & Links